medicalxpress - A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research …
AI Summary: A machine‑learning model trained on DNA methylation signatures can assign tissue‑of‑origin for cancers of unknown primary with promising accuracy. The approach could speed diagnosis, guide therapy choices and reduce reliance on invasive tests—handy when a tumor refuses to tell doctors where it came from.
Liquid biopsy blood test promises personalized lung cancer detection and monitoring / 4 days
AI face photos may predict cancer survival years earlier / 29 days
National study to use genetic testing to guide cancer survivor follow-up / 22 days
MYC overactivity enables DNA repair and chemotherapy resistance in tumours / 13 days
Prosigna-guided OPTIMA trial shows chemo can be safely skipped in many ER+/HER2− breast cancers / 25 hrs
Rogaratinib shows activity in SDH‑deficient GIST phase 2 trial / 43 hrs
Personalized glioblastoma vaccine shows early promise in trials / 18 days
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.